{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:44:33Z","timestamp":1762101873669,"version":"3.44.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.cellimm.2016.05.006","type":"journal-article","created":{"date-parts":[[2016,5,29]],"date-time":"2016-05-29T03:15:50Z","timestamp":1464491750000},"page":"25-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Intravenous immunoglobulin replacement treatment does not alter polymorphonuclear leukocytes function and surface receptors expression in patients with common variable immunodeficiency"],"prefix":"10.1016","volume":"306-307","author":[{"given":"Alessandro","family":"Prezzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filomena Monica","family":"Cavaliere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Bilotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Metello","family":"Iacobini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3328-7584","authenticated-orcid":false,"given":"Isabella","family":"Quinti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2016.05.006_b0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International consensus document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.cellimm.2016.05.006_b0010","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2009.07669.x","article-title":"Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions","volume":"6","author":"Chapel","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0015","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3349\/ymj.2012.53.3.603","article-title":"Health related quality of life in common variable immunodeficiency","volume":"53","author":"Quinti","year":"2012","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.cellimm.2016.05.006_b0020","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/asheducation.V2012.1.301.3798316","article-title":"The many faces of common variable immunodeficiency","author":"Cunningham-Rundles","year":"2012","journal-title":"Hematol. Am. Soc. Hematol. Educ. Prog."},{"key":"10.1016\/j.cellimm.2016.05.006_b0025","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s10875-007-9075-1","article-title":"Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency","volume":"27","author":"Quinti","year":"2007","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0030","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s12098-016-2038-x","article-title":"Common variable immunodeficiency","volume":"83","author":"Saikia","year":"2016","journal-title":"Indian J Pediatr."},{"key":"10.1016\/j.cellimm.2016.05.006_b0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0040","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10875-007-9169-9","article-title":"Prospective study on CVID patients with adverse reactions to intravenous or subcutaneous IgG administration","volume":"28","author":"Quinti","year":"2008","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0045","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1586\/eci.13.30","article-title":"A review on guidelines for management and treatment of common variable immunodeficiency","volume":"9","author":"Abolhassani","year":"2013","journal-title":"Exp. Rev. Clin. Immunol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12016-009-8155-9","article-title":"Evidence for the use of intravenous immunoglobulins \u2013 a review of the literature","volume":"38","author":"Kivity","year":"2010","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2014.00629","article-title":"Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in Europe","volume":"5","author":"Kerr","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0060","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.autrev.2012.02.006","article-title":"Intravenous immunoglobulin: exploiting the potential of natural antibodies","volume":"11","author":"Kaveri","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cellimm.2016.05.006_b0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2249.2011.04387.x","article-title":"Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy","volume":"2","author":"Kaveri","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0070","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/08916930902785363","article-title":"Intravenous immunoglobulin therapy for autoimmune diseases","volume":"42","author":"Arnson","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.cellimm.2016.05.006_b0075","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","article-title":"Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin","volume":"345","author":"Kazatchkine","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellimm.2016.05.006_b0080","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.immunol.26.021607.090232","article-title":"Anti-inflammatory actions of intravenous immunoglobulin","volume":"26","author":"Nimmerjahn","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0085","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1154315","article-title":"Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc","volume":"320","author":"Anthony","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2016.05.006_b0090","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3389\/fimmu.2014.00690","article-title":"Mechanisms of action of Ig preparations: immunomodulatory and anti-inflammatory effects","volume":"5","author":"Matucci","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0095","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3389\/fimmu.2014.00637","article-title":"Persistent immune activation in CVID and the role of IVIg in its suppression","volume":"5","author":"Paquin-Proulx","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0100","doi-asserted-by":"crossref","first-page":"e26469","DOI":"10.1371\/journal.pone.0026469","article-title":"A differential concentration-dependent effect of IVIg on neutrophil functions: relevance for anti-microbial and anti-inflammatory mechanisms","author":"Casulli","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cellimm.2016.05.006_b0105","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.immuni.2010.11.011","article-title":"Neutrophils, from marrow to microbes","volume":"33","author":"Borregaard","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2016.05.006_b0110","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1749-6632.1997.tb46269.x","article-title":"Host tissue damage by phagocytes","volume":"832","author":"Ricevuti","year":"1997","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1016\/j.cellimm.2016.05.006_b0115","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.46.1.250","article-title":"Reversible encephalopathy with cerebral vasospasm in a Guillain-Barr\u00e9 syndrome patient treated with intravenous immunoglobulin","volume":"46","author":"Voltz","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.cellimm.2016.05.006_b0120","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bbrc.2011.12.038","article-title":"Both the Fab and Fc domains of IgG are essential for ROS emission from TNF-\u03b1-primed neutrophils by IVIG","volume":"417","author":"Higurashi","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellimm.2016.05.006_b0125","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1046\/j.1365-2249.1998.00697.x","article-title":"Human intravenous immunoglobulin (IVIG) preparations degranulate human neutrophils in vitro","volume":"114","author":"Teeling","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0130","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1007\/s10875-010-9411-8","article-title":"Cell death modulation by intravenous immunoglobulin","volume":"1","author":"von Gunten","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0135","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/clim.2002.5209","article-title":"Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease","volume":"103","author":"Tsujimoto","year":"2002","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0140","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.4049\/jimmunol.170.6.3357","article-title":"Down-regulation of proinflammatory capacity during apoptosis in human polymorphonuclear leukocytes","volume":"170","author":"Kobayashi","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0145","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2249.2009.04081.x","article-title":"The other side of immunoglobulin G: suppressor of inflammation","volume":"160","author":"Aschermann","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0150","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4049\/jimmunol.173.1.332","article-title":"Monomeric IgG in intravenous Ig preparations is a functional antagonist of FcgammaRII and FcgammaRIIIb","volume":"173","author":"van Mirre","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0155","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/01.ta.0000215583.08765.ce","article-title":"Alteration of polymorphonuclear neutrophil surface receptor expression and migratory activity after isolation: comparison of whole blood and isolated PMN preparations from normal and post fracture trauma patients","volume":"60","author":"Pallister","year":"2006","journal-title":"J. Trauma"},{"key":"10.1016\/j.cellimm.2016.05.006_b0160","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/(SICI)1099-0844(200006)18:2<127::AID-CBF865>3.0.CO;2-V","article-title":"Oxidative metabolism and release of myeloperoxidase from polymorphonuclear leukocytes obtained from blood sedimentation in a Ficoll-Hypaque gradient","volume":"18","author":"Rebecchi","year":"2000","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.cellimm.2016.05.006_b0165","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.4049\/jimmunol.174.6.3633","article-title":"Inhibition of neutrophil apoptosis by TLR agonists in whole blood: involvement of the phosphoinositide 3-kinase\/Akt and NF-kappaB signaling pathways, leading to increased levels of Mcl-1, A1, and phosphorylated Bad","volume":"174","author":"Fran\u00e7ois","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0170","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.intimp.2015.07.017","article-title":"Intravenous immunoglobulin replacement induces an in vivo reduction of inflammatory monocytes and retains the monocyte ability to respond to bacterial stimulation in patients with common variable immunodeficiencies","volume":"28","author":"Cavaliere","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0175","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1007\/s10875-014-0031-6","article-title":"Role of Fc\u03b3RIIIA (CD16) in IVIg-mediated anti-inflammatory function","volume":"1","author":"Ben Mkaddem","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0180","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.4049\/jimmunol.159.8.3940","article-title":"Cross-linking of Fc gamma receptor IIa and Fc gamma receptor IIIb induces different proadhesive phenotypes on human neutrophils","volume":"159","author":"Kocher","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0185","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1568-9972(01)00002-7","article-title":"Pathogenic effects of anti-Fc gamma receptor IIIb (CD16) on polymorphonuclear neutrophils in non-organ-specific autoimmune diseases","volume":"1","author":"Youinou","year":"2002","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cellimm.2016.05.006_b0190","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1182\/blood.V84.7.2136.2136","article-title":"Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo","volume":"84","author":"Aukrust","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2016.05.006_b0195","doi-asserted-by":"crossref","first-page":"R120","DOI":"10.1186\/ar4575","article-title":"Low production of reactive oxygen species in granulocytes is associated with organ damage in systemic lupus erythematosus","volume":"16","author":"Bengtsson","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cellimm.2016.05.006_b0200","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1182\/blood-2004-04-1325","article-title":"Common variable immunodeficiency is associated with defective functions of dendritic cells","volume":"104","author":"Bayry","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2016.05.006_b0205","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.4049\/jimmunol.1301260","article-title":"Intravenous immunoglobulin treatment in humans suppresses dendritic cell function via stimulation of IL-4 and IL-13 production","volume":"192","author":"Tjon","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0210","first-page":"181","article-title":"Defective Fc-, CR1- and CR3 mediated monocyte phagocytosis and chemotaxis in common variable immunodeficiency and X-linked agammaglobulinemia patients","volume":"13","author":"Amoras","year":"2003","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0215","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1053\/shem.2002.31916","article-title":"Neutropenia associated with primary immunodeficiency syndromes","volume":"39","author":"Cham","year":"2002","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0220","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1182\/blood-2008-11-187302","article-title":"Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response","volume":"113","author":"Carlin","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2016.05.006_b0225","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.4049\/jimmunol.169.4.2003","article-title":"Complement receptor 3 (CD11b\/CD18) mediates type I and type II phagocytosis during nonopsonic and opsonic phagocytosis, respectively","volume":"169","author":"Le Cabec","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0230","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.4049\/jimmunol.143.10.3325","article-title":"Two leukocyte receptors (CD11a\/CD18 and CD11b\/CD18) mediate transient adhesion to endothelium by binding to different ligands","volume":"143","author":"Lo","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0235","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12026-014-8555-7","article-title":"Defective functions of polymorphonuclear neutrophils in patients with common variable immunodeficiency","volume":"60","author":"Casulli","year":"2014","journal-title":"Immunol. Res."},{"key":"10.1016\/j.cellimm.2016.05.006_b0240","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/cyto.1134","article-title":"Relationship between oxidative burst activity and CD11b expression in neutrophils and monocytes from healthy individuals: effects of race and gender","volume":"46","author":"Siddiqi","year":"2001","journal-title":"Cytometry"},{"key":"10.1016\/j.cellimm.2016.05.006_b0245","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fimmu.2015.00145","article-title":"A clinical and laboratory approach to the evaluation of innate immunity in pediatric CVID patients","volume":"6","author":"Kutukculer","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0250","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cellimm.2010.03.006","article-title":"Fcgamma receptors exhibit different phagocytosis potential in human neutrophils","volume":"263","author":"Rivas-Fuentes","year":"2010","journal-title":"Cell Immunol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0255","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1189\/jlb.72.6.1092","article-title":"Signal transduction during Fc receptor-mediated phagocytosis","volume":"72","author":"Garc\u00eda-Garc\u00eda","year":"2002","journal-title":"J. Leuoc. Biol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0260","doi-asserted-by":"crossref","first-page":"7847","DOI":"10.1016\/S0021-9258(18)34459-4","article-title":"Direct activation of calcium-activate, phospholipid-dependent protein kinase by tumor-promoting phorbol esters","volume":"257","author":"Castagna","year":"1982","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2016.05.006_b0265","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1073\/pnas.80.1.36","article-title":"Phorbol diester receptor copurifies with protein kinase C","volume":"80","author":"Niedel","year":"1983","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellimm.2016.05.006_b0270","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1172\/JCI112869","article-title":"Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins","volume":"79","author":"Henson","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellimm.2016.05.006_b0275","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJM198709103171107","article-title":"Current concepts: immunology. Neutrophils in human diseases","volume":"317","author":"Malech","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellimm.2016.05.006_b0280","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.clim.2011.01.002","article-title":"Preparations of intravenous immunoglobulins diminish the number and proinflammatory response of CD14+CD16++ monocytes in common variable immunodeficiency (CVID) patients","volume":"139","author":"Siedlar","year":"2011","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cellimm.2016.05.006_b0285","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jaut.2010.09.006","article-title":"Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: a mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies","volume":"36","author":"Bayry","year":"2011","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cellimm.2016.05.006_b0290","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s12026-014-8599-8","article-title":"Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces B cell depletion through differentiation into apoptosis-prone CD21(low) B cells","volume":"60","author":"Mitrevski","year":"2014","journal-title":"Immunol. Res."},{"key":"10.1016\/j.cellimm.2016.05.006_b0295","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10238-009-0061-1","article-title":"In vivo modulation of the expressions of Fas and CD25 by intravenous immunoglobulin in common variable immunodeficiency","volume":"10","author":"Artac","year":"2010","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.cellimm.2016.05.006_b0300","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.amjmed.2005.06.028","article-title":"Amelioration of differentiation of dendritic cells from CVID patients by intravenous immunoglobulin","volume":"118","author":"Bayry","year":"2005","journal-title":"Am. J. Med."},{"key":"10.1016\/j.cellimm.2016.05.006_b0305","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1182\/blood-2013-04-499442","article-title":"Dysregulated CD1 profile in myeloid dendritic cells in CVID is normalized by IVIg treatment","volume":"121","author":"Paquin-Proulx","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2016.05.006_b0310","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1182\/blood-2006-05-021568","article-title":"Immunologic and functional evidence for anti-Siglec-9 autoantibodies in intravenous immunoglobulin preparations","volume":"108","author":"von Gunten","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2016.05.006_b0315","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1182\/blood-2004-10-4112","article-title":"Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment","volume":"106","author":"von Gunten","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2016.05.006_b0320","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/SHK.0b013e3181a1bc98","article-title":"Different patterns of Siglec-9-mediated neutrophil death responses in septic shock","volume":"32","author":"von Gunten","year":"2009","journal-title":"Shock"},{"key":"10.1016\/j.cellimm.2016.05.006_b0325","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0022-1759(95)00003-S","article-title":"Effects of cell purification methods on CD11b and l-selectin expression as well as the adherence and activation of leucocytes","volume":"181","author":"Macey","year":"1995","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.cellimm.2016.05.006_b0330","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1006\/cyto.2000.0790","article-title":"Increased levels of apoptosis of leukocyte subsets in cultured PBMCs compared to whole blood as shown by Annexin V binding: relevance to cytokine production","volume":"12","author":"Hodge","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.cellimm.2016.05.006_b0335","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1600-0463.2005.apm_05.x","article-title":"Intravenous immunoglobulin preparations promote apoptosis in lipopolysaccharide-stimulated neutrophils via an oxygen-dependent pathway in vitro","volume":"113","author":"Takeshita","year":"2005","journal-title":"APMIS"}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874916300375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874916300375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T22:54:20Z","timestamp":1757804060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874916300375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":67,"alternative-id":["S0008874916300375"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2016.05.006","relation":{},"ISSN":["0008-8749"],"issn-type":[{"type":"print","value":"0008-8749"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous immunoglobulin replacement treatment does not alter polymorphonuclear leukocytes function and surface receptors expression in patients with common variable immunodeficiency","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2016.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}